share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144：拟议出售证券

SEC announcement ·  01/02 00:00
Moomoo AI 已提取核心信息
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 1,325 shares of common stock on 01/02/2024, as per the latest filing. The shares, acquired through a restricted stock vest on 12/30/2023, are to be sold at an aggregate market value of $4,691.56. This transaction follows a period where no other securities were sold by Burnett in the past three months.
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 1,325 shares of common stock on 01/02/2024, as per the latest filing. The shares, acquired through a restricted stock vest on 12/30/2023, are to be sold at an aggregate market value of $4,691.56. This transaction follows a period where no other securities were sold by Burnett in the past three months.
根据最新文件，Arcutis Biotherapeutics, Inc.高管伯内特·帕特里克定于2024年2月1日出售1,325股普通股。这些股票于2023年12月30日通过限制性股票背心收购，将以4,691.56美元的总市值出售。这笔交易是在伯内特在过去三个月中没有出售其他证券的时期之后进行的。
根据最新文件，Arcutis Biotherapeutics, Inc.高管伯内特·帕特里克定于2024年2月1日出售1,325股普通股。这些股票于2023年12月30日通过限制性股票背心收购，将以4,691.56美元的总市值出售。这笔交易是在伯内特在过去三个月中没有出售其他证券的时期之后进行的。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息